BriaCell Therapeutics Corp.BriaCell Therapeutics Corp.BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

No trades
See on Supercharts

Key stats

Market capitalization
‪35.52 M‬USD
Dividend yield (indicated)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
Net income (FY)
Revenue (FY)
Shares float
Beta (1Y)
1.57

About BRIACELL THERAPEUTICS CORP

CEO
William V. Williams
Headquarters
West Vancouver
Founded
2006
FIGI
BBG00ZF3B328
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.